Aytu BioPharma, Inc. Public Market Comparables
Find the most relevant public market comparables for Aytu BioPharma, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Aytu BioPharma, Inc. is a specialty pharmaceutical company focused on commercializing novel therapeutics. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), and has a commercial portfolio of prescription therapeutics and consumer health products.
Business Model
Commercialization of novel therapeutics and consumer health products through prescription sales and direct marketing.
Target Customers
Patients requiring treatment for ADHD, urological conditions, male infertility, and those seeking sexual wellness products; healthcare providers.
Specific Focus
ADHD treatments, urology products, male infertility diagnostics and treatments, sexual wellness products.
Location
Denver, Colorado
CEO
Josh Disbrow
Industry
Life sciences
Sub Sector
Specialty Pharmaceuticals
3yr Revenue Growth
289%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Aytu BioPharma, Inc. in the Pharmaceuticals sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Aytu BioPharma, Inc.? Our platform provides detailed analysis of Aytu BioPharma, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Aytu BioPharma, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Aytu BioPharma, Inc. Compset
As a leading player in the Life sciences industry within the Pharmaceuticals sector, Aytu BioPharma, Inc. operates in the specialized Specialty Pharmaceuticals sub-sector. Understanding how Aytu BioPharma, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Specialty Pharmaceuticals space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Marinus Pharmaceuticals, Inc.
Pharmaceuticals • Life sciences
Marinus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapeutics to treat seizure disorders. Its product, ZTALMY® (ganaxolone) oral suspension CV, is an FDA-approved prescription medication for CDKL5 deficiency disorder.
Click Therapeutics
Life Sciences • Life sciences
Click Therapeutics develops and commercializes software as prescription medical treatments for people with unmet medical needs. Their digital therapeutics (DTx) utilize cognitive and neurobehavioral mechanisms to drive change and are designed for independent use or in conjunction with traditional treatments. They offer treatments for various conditions including major depressive disorder, schizophrenia, opioid use disorder, insomnia, migraines, type 2 diabetes, and multiple sclerosis. The company utilizes the Clickometrics® adaptive data science platform to personalize user experience and optimize outcomes.
Y-mAbs Therapeutics, Inc.
Biotechnology • Life sciences
Y-mAbs Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel, antibody-based therapeutic products for cancer treatment. They utilize technologies such as their investigational Self-Assembly DisAssembly (SADA) Pretargeted Radioimmunotherapy Platform and bispecific antibodies generated using the Y-BiClone platform. Their product pipeline includes DANYELZA (naxitamab-gqgk), an FDA-approved treatment for relapsed or refractory neuroblastoma.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Aytu BioPharma, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free